Page last updated: 2024-11-03

ro 31-8220 and Colonic Neoplasms

ro 31-8220 has been researched along with Colonic Neoplasms in 3 studies

Ro 31-8220: a protein kinase C inhibitor

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calvo, N1
Gentili, C1
de Boland, AR1
Graness, A1
Adomeit, A1
Heinze, R1
Wetzker, R1
Liebmann, C1
Pajak, B1
Turowska, A1
Orzechowski, A1
Gajkowska, B1

Other Studies

3 other studies available for ro 31-8220 and Colonic Neoplasms

ArticleYear
Parathyroid hormone and the regulation of cell cycle in colon adenocarcinoma cells.
    Biochimica et biophysica acta, 2011, Volume: 1813, Issue:10

    Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Benzophenanthridines; Caco-2 Cells; Cell Cycle;

2011
A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon.
    The Journal of biological chemistry, 1998, Nov-27, Volume: 273, Issue:48

    Topics: Bradykinin; Calcium-Calmodulin-Dependent Protein Kinases; Chromones; Colonic Neoplasms; Dimerization

1998
Bisindolylmaleimide IX facilitates extrinsic and initiates intrinsic apoptosis in TNF-alpha-resistant human colon adenocarcinoma COLO 205 cells.
    Apoptosis : an international journal on programmed cell death, 2008, Volume: 13, Issue:4

    Topics: Adenocarcinoma; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 9; Cell Line, T

2008